A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of Belimumab in a Subgroup of Systemic Lupus Erythematosus (SLE) Patients
with Higher Disease Activity (anti-dsDNA positive and low complement): A Pooled Analysis of
the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies